Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells
about
sameAs
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myelomaOsteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancyInducible hyaluronan production reveals differential effects on prostate tumor cell growth and tumor angiogenesisSmart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriersThe Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle.Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cellsStromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptorA novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone.A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells.The interaction between LYVE-1 with hyaluronan on the cell surface may play a role in the diversity of adhesion to cancer cells.Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing.Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in miceChronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.Inhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosisHyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M.Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised miceHyaluronan and hyaluronidase in genitourinary tumors.Integrins in prostate cancer progressionAberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancerSpatial organization and mechanical properties of the pericellular matrix on chondrocytes.Sugars in the microenvironment: the sticky problem of HA turnover in tumors.Two novel functions of hyaluronidase-2 (Hyal2) are formation of the glycocalyx and control of CD44-ERM interactionsCarcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment.Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.Hyaluronic acid in digestive cancers.In vitro model of hyaluronan synthase gene expression associated with lipopolysaccharide-induced inflammation in SW982 cell line.Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance.Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels.Hyaluronan promotes the chondrocyte response to BMP-7.Caution should be used in long-term treatment with oral compounds of hyaluronic acid in patients with a history of cancer.Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation.Systemic blockade of the hyaluronan receptor for endocytosis prevents lymph node metastasis of prostate cancer.Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells.Hyaluronan and tumor growth.A Trickster in Disguise: Hyaluronan's Ambivalent Roles in the Matrix.Self-assembly and elasticity of hierarchical proteoglycan–hyaluronan brushes† †Electronic supplementary information (ESI) available: Variations in areal mass density upon SLB and SAv monolayer formation determined by SE (Fig. S1). See DOI: 10.1039/cPrognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias - assessment of clinical outcome, post induction, end of treatment and minimal residual disease
P2860
Q24670483-9E156D09-2236-435D-A622-80F642E34E2FQ28249112-1594726A-56D0-4209-9F8E-7ED4B649283EQ28302215-8868BD01-B6EA-4A0E-9942-264B650E026EQ28817755-DAA35762-30AE-4032-832C-291BA826E07DQ33361929-15B7982E-FBAA-4C04-BBAD-53016A435298Q33801685-738D6CA1-04EF-4612-AEA1-5551695B6562Q33924267-9EF5B1BE-DFF8-45B0-B96B-79AC98F77A98Q34326198-4DC6B877-6626-47BC-A451-D0A93DC5D9DAQ34414905-1C1002F8-29FD-4CCA-B302-A65156BFF015Q34744147-DBFB339E-293D-4739-8AAC-6F218E6A92D0Q34945220-5B1B649A-6F73-48D1-996F-A619C3BDA2F1Q35221910-FF4D3D92-D7F2-4090-8EDC-6910C7A0F210Q35440662-0A6A3E2C-4949-43C8-B8EE-42496B6480A6Q35693859-574C5663-4087-4672-9D4D-7F326BDDB9B8Q35781386-D0995202-F644-4276-BDE6-99450CD14AEBQ35789173-736ADB87-4D07-4250-B226-64FEAAFF7FB3Q37072219-99980758-F534-4E15-B16E-2EBBD88E96C0Q37182177-1AB4828D-879F-4656-809B-6FE5F0E5EC11Q37253985-3C87F73A-D7A6-4582-9701-A3EC7BB762EAQ37409680-D3E029ED-D88A-4CD3-9114-629C5CF4E3DDQ38260975-2F295475-7CD4-4448-B200-0F0914C77358Q38350133-2165409A-DF3B-422B-905B-4444998F126BQ38838567-5BC03361-A53C-4F16-9B40-0004A24FC593Q38927595-0FFE3E99-52F7-4C79-8E37-52119212DA0FQ38930438-FB6C426B-AE16-4ADE-8253-70AD90C997E0Q38984245-7C7C8D49-AEB0-41F8-8E40-CE42621EE568Q39023950-1A0D7907-364C-4183-8012-0CD766C4F2DFQ39879669-7E99F6FC-60A0-414E-AB00-DB4A5B11A869Q40035670-C197B604-914B-49CF-A9B6-3713C497785DQ40496192-2710CC91-25F0-4DE3-A31F-1AE5054B84EDQ40599276-4377F54B-6DCB-4B81-8763-9CE3A7EDC9FDQ41116062-15C098B7-FED9-4AB1-A643-2355E425F104Q41843755-F4FAEDBC-CB2E-4E98-AFE6-E65F1DB40BC6Q42794422-F4FB27F0-33E4-4B36-AEC0-6602F8E097C6Q46276542-F04A78B7-A53C-4C52-9367-1AC1F44F4FCAQ46896464-BEFCEBD6-54C9-4E4B-AB0A-7F41DB04927FQ58124882-C74F5B97-46D6-4071-93E4-C24220A1F93E
P2860
Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@ast
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@en
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@nl
type
label
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@ast
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@en
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@nl
prefLabel
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@ast
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@en
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@nl
P2093
P2860
P921
P3181
P356
P1476
Manipulation of hyaluronan syn ...... bone marrow endothelial cells
@en
P2093
Andrew P Spicer
Christopher M Wilson
James B McCarthy
Leo T Furcht
Melanie A Simpson
Theodore R Oegema
P2860
P304
P3181
P356
10.1074/JBC.M110069200
P407
P577
2002-03-22T00:00:00Z